Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280528057> ?p ?o ?g. }
- W4280528057 endingPage "5664" @default.
- W4280528057 startingPage "5664" @default.
- W4280528057 abstract "Although many efforts have been made to elucidate the pathogenesis of COVID-19, the underlying mechanisms are yet to be fully uncovered. However, it is known that a dysfunctional immune response and the accompanying uncontrollable inflammation lead to troublesome outcomes in COVID-19 patients. Pannexin1 channels are put forward as interesting drug targets for the treatment of COVID-19 due to their key role in inflammation and their link to other viral infections. In the present study, we selected a panel of drugs previously tested in clinical trials as potential candidates for the treatment of COVID-19 early on in the pandemic, including hydroxychloroquine, chloroquine, azithromycin, dexamethasone, ribavirin, remdesivir, favipiravir, lopinavir, and ritonavir. The effect of the drugs on pannexin1 channels was assessed at a functional level by means of measurement of extracellular ATP release. Immunoblot analysis and real-time quantitative reversetranscription polymerase chain reaction analysis were used to study the potential of the drugs to alter pannexin1 protein and mRNA expression levels, respectively. Favipiravir, hydroxychloroquine, lopinavir, and the combination of lopinavir with ritonavir were found to inhibit pannexin1 channel activity without affecting pannexin1 protein or mRNA levels. Thusthree new inhibitors of pannexin1 channels were identified that, though currently not being used anymore for the treatment of COVID-19 patients, could be potential drug candidates for other pannexin1-related diseases." @default.
- W4280528057 created "2022-05-22" @default.
- W4280528057 creator A5002859621 @default.
- W4280528057 creator A5038739123 @default.
- W4280528057 creator A5040367251 @default.
- W4280528057 creator A5040659202 @default.
- W4280528057 creator A5043376833 @default.
- W4280528057 creator A5045862213 @default.
- W4280528057 creator A5056011321 @default.
- W4280528057 creator A5063612507 @default.
- W4280528057 creator A5074433514 @default.
- W4280528057 creator A5085792549 @default.
- W4280528057 creator A5086007558 @default.
- W4280528057 date "2022-05-18" @default.
- W4280528057 modified "2023-10-18" @default.
- W4280528057 title "Effects of Drugs Formerly Suggested for COVID-19 Repurposing on Pannexin1 Channels" @default.
- W4280528057 cites W1053624528 @default.
- W4280528057 cites W1709477531 @default.
- W4280528057 cites W1965130745 @default.
- W4280528057 cites W1971084572 @default.
- W4280528057 cites W1978688152 @default.
- W4280528057 cites W1989816038 @default.
- W4280528057 cites W1998287336 @default.
- W4280528057 cites W2002060477 @default.
- W4280528057 cites W2009948435 @default.
- W4280528057 cites W2022023926 @default.
- W4280528057 cites W2022134062 @default.
- W4280528057 cites W2026907317 @default.
- W4280528057 cites W2035678827 @default.
- W4280528057 cites W2051678628 @default.
- W4280528057 cites W2071235764 @default.
- W4280528057 cites W2072542349 @default.
- W4280528057 cites W2075086629 @default.
- W4280528057 cites W2085780740 @default.
- W4280528057 cites W2101659916 @default.
- W4280528057 cites W2102694854 @default.
- W4280528057 cites W2104285627 @default.
- W4280528057 cites W2104736692 @default.
- W4280528057 cites W2105711740 @default.
- W4280528057 cites W2107448617 @default.
- W4280528057 cites W2108244474 @default.
- W4280528057 cites W2137500094 @default.
- W4280528057 cites W2142715166 @default.
- W4280528057 cites W2144414541 @default.
- W4280528057 cites W2164349191 @default.
- W4280528057 cites W2274680001 @default.
- W4280528057 cites W2300256671 @default.
- W4280528057 cites W2302415776 @default.
- W4280528057 cites W2340761255 @default.
- W4280528057 cites W2396140054 @default.
- W4280528057 cites W2531441777 @default.
- W4280528057 cites W2533912097 @default.
- W4280528057 cites W2590352307 @default.
- W4280528057 cites W2614544395 @default.
- W4280528057 cites W2728927239 @default.
- W4280528057 cites W2732174516 @default.
- W4280528057 cites W2736696812 @default.
- W4280528057 cites W2768224243 @default.
- W4280528057 cites W2790847363 @default.
- W4280528057 cites W2809684258 @default.
- W4280528057 cites W2888198515 @default.
- W4280528057 cites W2944160152 @default.
- W4280528057 cites W2968698979 @default.
- W4280528057 cites W2989755687 @default.
- W4280528057 cites W2991611679 @default.
- W4280528057 cites W3000413850 @default.
- W4280528057 cites W3004709581 @default.
- W4280528057 cites W3005212621 @default.
- W4280528057 cites W3010985052 @default.
- W4280528057 cites W3012379316 @default.
- W4280528057 cites W3014003872 @default.
- W4280528057 cites W3016727251 @default.
- W4280528057 cites W3017243701 @default.
- W4280528057 cites W3017334158 @default.
- W4280528057 cites W3025333652 @default.
- W4280528057 cites W3025536642 @default.
- W4280528057 cites W3027562820 @default.
- W4280528057 cites W3033778103 @default.
- W4280528057 cites W3037490455 @default.
- W4280528057 cites W3039185763 @default.
- W4280528057 cites W3041206342 @default.
- W4280528057 cites W3043659712 @default.
- W4280528057 cites W3044956986 @default.
- W4280528057 cites W3046348463 @default.
- W4280528057 cites W3087796548 @default.
- W4280528057 cites W3091616760 @default.
- W4280528057 cites W3093630651 @default.
- W4280528057 cites W3108665741 @default.
- W4280528057 cites W3114165882 @default.
- W4280528057 cites W3118636209 @default.
- W4280528057 cites W3119610674 @default.
- W4280528057 cites W3123471725 @default.
- W4280528057 cites W3130060129 @default.
- W4280528057 cites W3136278767 @default.
- W4280528057 cites W3153676716 @default.
- W4280528057 cites W3158990623 @default.
- W4280528057 cites W3159307070 @default.
- W4280528057 cites W3165273093 @default.